TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2023
Back to search
Official data from USPTO
AM ANTAROS MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
11/17/2023
Trademark type
Combined
Nice classes
42, 44
Filing date
08/11/2020
Registration date
11/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2021
Last transaction
11/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Mölndal, SE
Examiner
NEPTUNE, EVONNE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "AM" with the letter "A" made up of a light blue arch, a red arch, and a dark blue rectangle, and with the letter "M" made up of a purple arch, a pink rectangle and a green rectangle, all appearing in larger font to the left of the stacked stylized words "ANTAROS MEDICAL" in black. The white represents background and is not a feature of the mark.
Holders and representatives
Holders
Antaros Medical AB
Representatives
Sara M. Bauer Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Consultancy relating to drug development; drug discovery services; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to scientific research focusing on imaging and development of pharmaceuticals; scientific research for development of pharmaceuticals and for medical purposes; pharmaceuticals research relating to imaging; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research services; industrial analysis and research services in the field of pharmaceuticals; biochemistry research services; provision of information and data relating to medical and veterinary pharmaceutical research and development; preparing and providing medical and scientific research information and reports in relation to pharmaceuticals and clinical tests; research and development relating to imaging for the pharmaceuticals industry; conducting clinical trialsfor others; conducting clinical trials for pharmaceutical products for others; clinical research relating to imaging; medical research relating to imaging; scientific research relating to imaging; development of test methodsspecificationsprocedurestechniques relating to imaging; research and development relating to imaging; scientific research and development relating to imaging; scientific research and analysis in the field of development of pharmaceuticals; development in relation to methodsspecificationsprocedurestechniques for testing relating to imaging; services relating to pharmaceutical research and development relating to imaging; research and development in the pharmaceuticals and biotechnology fields relating to imaging; scientific and technological services relating to imagingresearch; scientific services and design relating thereto relating to imagingnamely clinical research in the field of pharmaceuticals; scientific services and research relating thereto relating to imagingnamely clinical research in the field of pharmaceuticals; analytical laboratory servicesmedical imaging analysis; testingauthentication and quality control in the field of pharmaceuticalsfor others; quality assurance consultancy in the field of pharmaceuticals; clinical study design services; pharmaceutical drug development servicesanalysis of X-ray images for drug development; compilation of data in the nature of medical reports for research purposes
Class 44
x-ray technician services; medical evaluation services for pharmaceutical research and development; medical imaging services; advisory services relating to medical services; advisory services relating to pharmaceuticals; issuing of medical reports in the field of pharmaceutical research and development; compilation of data in the nature of medical reports for diagnostic purposes; conducting of medical examinations for pharmaceutical research and development; x-ray examinations for medical purposes; medical diagnostic services; preparation of reports relating to medical matters for pharmaceutical research and development; advisory services relating to medical instruments; all the aforesaid services in this class being used for providing medical information on the development of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
20 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2020
GNRT
NON-FINAL ACTION E-MAILED
12/06/2020
CNRT
NON-FINAL ACTION WRITTEN
12/06/2020
DOCK
ASSIGNED TO EXAMINER
12/05/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2020
NWAP
NEW APPLICATION ENTERED
08/14/2020
Continuous trademark protection
Get notified about every new filing that threatens AM ANTAROS MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.